Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20355)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | GR50 | GRmax | GR_AOC | GEC50 | GRinf | GR Hill Coefficient | GR r2 | pval_GR |
---|---|---|---|---|---|---|---|---|---|
MCF 10A | GSK2334470 | 15.0731115613 | 0.8830 | -0.0129 | 18.7770 | -1.0000 | 5.0000 | 0.4636 | 0.000172093714918 |
MDA-MB-453 | AZD5363 | 1.537709354 | 0.1686 | 0.2591 | 1.2036 | 0.0741 | 0.6549 | 0.8588 | 2.35e-11 |
SUM149PT | LY3023414 | 1.560308156 | -0.0238 | 0.2943 | 18.4015 | -1.0000 | 0.4452 | 0.8188 | 5.32e-10 |
HCC38 | Senexin B | 15.63810324 | 0.5236 | 0.1411 | 269.9088 | -0.9985 | 0.3853 | 0.5885 | 1.51e-05 |
MDA-MB-468 | SHP099 | 15.69903996 | 0.5419 | 0.1218 | 54.5394 | -0.4817 | 0.5418 | 0.5522 | 4.35e-05 |
CAL-85-1 | Rucaparib | 15.9069887 | 0.3496 | 0.2765 | 1000.0000 | -0.6758 | 0.2065 | 0.3127 | 0.009204617 |
HCC1143 | Senexin B | 16.15394735 | 0.4142 | 0.1852 | 1000.0000 | -0.7697 | 0.2259 | 0.6559 | 1.62e-06 |
MDA-MB-468 | Ulixertinib | 1.621194239 | 0.3429 | 0.2660 | 0.2539 | 0.3452 | 0.6324 | 0.9377 | 8.88e-16 |
HME1 | SHP099 | 16.29543423 | 0.6344 | 0.0890 | 71.5373 | -1.0000 | 0.7426 | 0.7358 | 5.94e-08 |
HCC70 | Senexin B | 16.531300381 | 0.4078 | 0.2194 | 1000.0000 | -0.7732 | 0.2278 | 0.4788 | 0.000290238214042 |
HCC1806 | Ribociclib | 168.232015049 | 0.6251 | 0.1419 | 317.3038 | -0.1285 | 0.3606 | 0.3213 | 0.00787309835959 |
HCC1143 | Ulixertinib | 1.718095034 | 0.0344 | 0.2458 | 19.1869 | -1.0000 | 0.4553 | 0.8884 | 1.25e-12 |
BT-20 | AZD5363 | 1.72900360981 | 0.1717 | 0.3013 | 86.6237 | -1.0000 | 0.2807 | 0.8604 | 2.05393480002e-11 |
HCC1143 | RO-3306 | 1.73126532 | -0.1079 | 0.2418 | 3.9460 | -0.5002 | 0.8416 | 0.9451 | 2.22e-16 |
HCC70 | AZD6738 | 1.73555477677 | -0.5435 | 0.2705 | 4.4527 | -1.0000 | 1.1660 | 0.9336 | 1.88737914186e-15 |
MDA-MB-361 | Senexin B | 1.759420996 | 0.3235 | 0.2847 | 157.3873 | -1.0000 | 0.2445 | 0.4951 | 0.000194933 |
SUM1315MO2 | Rucaparib | 17.80541463 | 0.2942 | 0.3317 | 1000.0000 | -0.3226 | 0.1236 | 0.3203 | 0.008018079 |
HCC1806 | AZD2014 | 1.79837045193 | 0.3811 | 0.3438 | 2.3555 | -0.0311 | 0.2238 | 0.8823 | 2.43538522682e-12 |
BT-20 | MK 1775 | 1.80498033053 | -0.6583 | 0.2015 | 4.1869 | -1.0000 | 1.3057 | 0.9322 | 2.44249065418e-15 |
SUM159PT | Rucaparib | 1.81722e+11 | 0.7797 | 0.0896 | 999.9789 | 0.4809 | 0.1718 | 0.3608 | 0.003721786 |
MDA-MB-231 | GSK2334470 | 186.872396201 | 0.5782 | 0.1537 | 1000.0000 | -0.2356 | 0.2301 | 0.5852 | 1.67193823907e-05 |
SUM149PT | AZD2014 | 1.870533874 | 0.3557 | 0.3916 | 1000.0000 | -0.6285 | 0.1296 | 0.8137 | 7.57e-10 |
HCC1395 | Ulixertinib | 1.871580782 | 0.1659 | 0.2498 | 4.1054 | -0.2114 | 0.4489 | 0.7753 | 7.87e-09 |
Hs 578T | GSK2334470 | 19.04682987 | 0.5381 | 0.1513 | 619.2531 | -1.0000 | 0.3155 | 0.9434 | 2.22e-16 |
SUM159PT | Ulixertinib | 1.943050817 | 0.1333 | 0.2476 | 22.3099 | -1.0000 | 0.4501 | 0.9582 | 1.11e-16 |